GPP

Great Point Partners Portfolio holdings

AUM $154M
1-Year Est. Return 2.36%
This Quarter Est. Return
1 Year Est. Return
-2.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$945M
AUM Growth
+$122M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
41
New
Increased
Reduced
Closed

Top Buys

1
+$40.3M
2
+$38.7M
3
+$37.5M
4
ZYME icon
Zymeworks
ZYME
+$34.8M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
+$24.9M

Top Sells

1
+$25.8M
2
+$19.3M
3
+$15.3M
4
FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
+$5.02M
5
RVLP
RVL Pharmaceuticals plc Ordinary Shares
RVLP
+$3.52M

Sector Composition

1 Healthcare 98.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
26
$8.36M 0.77%
+222,222
27
$7.4M 0.68%
22,945
-1,137
28
$7.31M 0.67%
+129,424
29
$7.06M 0.65%
+20,000
30
$5.48M 0.5%
+309,700
31
$2.96M 0.27%
25,000
32
$1.69M 0.16%
+325,000
33
$193K 0.02%
+92,140
34
$141K 0.01%
8,676
35
– –
0
36
– –
-184,266
37
– –
-926,933
38
– –
-547,712
39
– –
-2,110,071
40
– –
0
41
– –
-350,000
1
2